Skip to main content

Advertisement

Log in

Cyclosporin A for the treatment of severe Henoch-Schönlein glomerulonephritis

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

We evaluated the efficacy of cyclosporin A (CyA) for treating pediatric patients with severe Henoch-Schönlein glomerulonephritis (HSP-GN) and nephrotic-range proteinuria. Seven pediatric HSP-GN patients (5 boys, 2 girls) were treated with CyA, with a mean age of 10.6 years at diagnosis (range 7.2–15.2 years) and mean follow-up times of 6.0 years (range 4.4–8.9 years) from diagnosis and 5.2 years (range 3.4–7.7 years) from the beginning of the CyA treatment. All had developed nephrotic-range proteinuria within 1–3 months of the HSP diagnosis. A renal biopsy was performed on all the patients, and two showed rapidly progressive glomerulonephritis. They all received additional angiotensin converting enzyme inhibitor medication and one to three types of immunosuppressive treatment had been tried in five of the seven patients before CyA was initiated at a mean interval of 0.7 years after diagnosis (range 0.1–2.0 years). All the patients responded to the CyA treatment within a mean of 1.4 months (range 1 week to 4 months). Four patients achieved a stable remission and had been without CyA treatment for a mean of 3.7 years (range 2.9–5.3 years) by the end of the follow-up. Three patients seemed to become CyA dependent, since they developed proteinuria when the treatment was stopped. CyA treatment had been started significantly earlier (P=0.045) in the former group (mean 0.2 years, range 0.1–0.3 years) than in the latter (mean 1.5 years, range 1.2–2.0 years). Renal function was preserved in all patients, the glomerular filtration rate, plasma cystatin C, serum albumin, and serum creatinine being within normal limits at the end of the follow-up. We conclude that CyA treatment for severe treatment-resistant HSP-GN is promising, since four of the seven patients enjoy stable remission and all have retained their renal function after a mean follow-up of 6.0 years. However, some patients seem to develop CyA-dependent nephritis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.

Similar content being viewed by others

References

  1. Koskimies O, Mir S, Rapola J, Vilska J (1981) Henoch-Schönlein nephritis: long-term prognosis of unselected patients. Arch Dis Child 56:482–484

    CAS  PubMed  Google Scholar 

  2. Ronkainen J, Nuutinen M, Koskimies O (2002) The adult kidney 24 years after childhood Henoch-Schönlein purpura: a retrospective cohort study. Lancet 360:666–670

    Article  PubMed  Google Scholar 

  3. Ronkainen J, Ala-Houhala M, Huttunen N-P, Jahnukainen T, Koskimies O, Örmälä T, Nuutinen M (2003) Outcome of Henoch-Schönlein nephritis with nephrotic-range proteinuria. Clin Nephrol 60:80–84

    Google Scholar 

  4. Goldstein AR, White RH, Akuse R, Chantler C (1992) Long-term follow-up of childhood Henoch-Schönlein nephritis. Lancet 339:280–282

    CAS  PubMed  Google Scholar 

  5. Niaudet P, Habib R (1998) Methylprednisolone pulse therapy in the treatment of severe forms of Schonlein-Henoch nephritis. Pediatr Nephrol 12:238–243

    Article  CAS  PubMed  Google Scholar 

  6. Öner A, Tinaztepe K, Erdogan Ö (1995) The effect of triple therapy on rapidly progressive type of Henoch-Schönlein nephritis. Pediatr Nephrol 9:6–10

    Google Scholar 

  7. Foster BJ, Bernard C, Drummond KN, Sharma AK (2002) Effective therapy for severe Henoch-Schonlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study. J Pediatr 136:370–375

    Google Scholar 

  8. Iijima K, Ito-Kariya S, Nakamura H, Yoshikawa N (1998) Multiple combined therapy for severe Henoch-Schonlein nephritis in children. Pediatr Nephrol 12:244–248

    Article  CAS  PubMed  Google Scholar 

  9. Tanaka H, Suzuki K, Nakahata T, Ito E, Waga S (2003) Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis. Pediatr Nephrol 18:347–350

    Google Scholar 

  10. Inoue Y, Iijima K, Nakamura H, Yoshikawa N (1999) Two-year cyclosporin treatment in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol 13:33–38

    CAS  PubMed  Google Scholar 

  11. Niaudet P and the French Society of Pediatric Nephrology (1994) Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone. J Pediatr 125:981–986

    CAS  PubMed  Google Scholar 

  12. Ponticelli C, Rizzoni G, Edefonti A, Altieri P, Rivolta E, Rinaldi S, Ghio L, Lusvarghi E, Gusmano R, Locatelli F (1993) A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int 43:1377–1384

    CAS  PubMed  Google Scholar 

  13. Tanaka R, Yoshikawa N, Kitano Y, Ito H, Nakamura H (1993) Long-term cyclosporin treatment in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol 7:249–252

    CAS  PubMed  Google Scholar 

  14. Schmaldienst S, Winkler S, Breiteneder S, Hörl WH (1997) Severe nephrotic syndrome in a patient with Schönlein-Henoch purpura: complete remission after cyclosporin A. Nephrol Dial Transplant 12:790–792

    Google Scholar 

  15. Catalano C, Fabbian F, Bordin V, Di Landro D (1998) Failure of cyclosporine A in controlling Schoenlein-Henoch purpura. Nephrol Dial Transplant 13:1605–1606

    Google Scholar 

  16. Counahan R, Winterborn MH, White RHR, Heaton JM, Meadow SR, Bluett NH, Swetschin HS, Cameron JS, Chantler C (1977) Prognosis of Henoch-Schönlein nephritis in children. BMJ 2:11–14

    CAS  PubMed  Google Scholar 

  17. Sairam VK, Kalia A, Rajaraman S, Travis LB (2002) Secondary resistance to cyclosporin A in children with nephrotic syndrome. Pediatr Nephrol 17:842–846

    Google Scholar 

  18. Thervet E, Pillebout E, Guillevin L (2003) Outcome after childhood Henoch-Schonlein purpura. Lancet 361:81–82

    Article  CAS  Google Scholar 

  19. Maschio G, Alberti D, Janin G, Locatelli F, Mann J, Motolese M, Ponticelli C, Ritz E, Zucchelli P (1996) Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 334:939–945

    Google Scholar 

  20. Hausberg M, Barenbrock M, Hohage H, Muller S, Heidenreich S, Rahn K-H (1999) ACE inhibitor versus β-blocker for the treatment of hypertension in renal allograft recipients. Hypertension 33:862–868

    PubMed  Google Scholar 

  21. Anarat A, Noyan A, Gonlusen G, Duman N, Tuncer D (1996) Influence of enalapril on experimental cyclosporin A nephrotoxicity. Pediatr Nephrol 10:616–620

    Google Scholar 

  22. Seikaly MG, Prashner H, Nolde-Hurlbert B, Browne R (2002) Long-term clinical and pathological effect of cyclosporin in children with nephrosis. Pediatr Nephrol 14:214–217

    Google Scholar 

  23. Iijima K, Hamahira K, Tanaka R, Kobayashi A, Nozu K, Nakamura H, Yoshikawa N (2002) Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome. Kidney Int 61:1801–1805

    Article  PubMed  Google Scholar 

  24. Kano K, Kyo K, Yamada Y, Ito S, Ando T, Arisaka O (2001) Comparison between pre- and posttreatment clinical and renal biopsies in children receiving low doses cyclosporine-A for 2 years for steroid-dependent nephrotic syndrome. Clin Nephrol 52:19–24

    Google Scholar 

  25. Habib R, Niaudet P (1994) Comparison between pre and post treatment renal biopsies in children receiving cyclosporine for idiopathic nephrosis. Clin Nephrol 42:1446–1456

    Google Scholar 

Download references

Acknowledgements

This work was supported by a grant from the Alma and K.A. Snellman Foundation to the first author for leave of absence.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Matti Nuutinen.

Additional information

The results were presented as a poster at the 36th meeting of the European Society for Pediatric Nephrology in Bilbao

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ronkainen, J., Autio-Harmainen, H. & Nuutinen, M. Cyclosporin A for the treatment of severe Henoch-Schönlein glomerulonephritis. Pediatr Nephrol 18, 1138–1142 (2003). https://doi.org/10.1007/s00467-003-1245-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-003-1245-7

Keywords

Navigation